NASDAQ:CTSO
Cytosorbents Corporation Stock News
$0.97
+0.101 (+11.69%)
At Close: May 17, 2024
Coronavirus update: 1.89 million cases worldwide, 118,304 deaths; and Trump attacks Dr. Fauci and the New York Times
07:31pm, Monday, 13'th Apr 2020
The U.S. death toll from COVID-19 rose above 22,000 on Monday, as President Donald Trump railed against the nation’s top infectious disease expert for...
CytoSorbents Gains Emergency Authorization for Covid-19 Treatment
03:44pm, Monday, 13'th Apr 2020
The FDA says CytoSorbents' blood purification system 'may be effective' in fighting cytokine storms.
Stocks That Hit 52-Week Highs On Monday
02:25pm, Monday, 13'th Apr 2020
On Monday, these stocks hit new 52-week highs.
Intriguing Points:
Dollar General (NYSE: DG) was the smallest company by market cap to set a new 52-week high
Of the...
CytoSorbents' stock jumps on FDA authorization for its device in COVID-19 patients
02:06pm, Monday, 13'th Apr 2020
Shares of CytoSorbents Corp. undefined gained 28.7% in trading on Monday following a Food and Drug Administration announcement late on Friday that grants an...
CytoSorbents' stock jumps on FDA authorization for its device in COVID-19 patients
02:06pm, Monday, 13'th Apr 2020
Shares of CytoSorbents Corp. gained 28.7% in trading on Monday following a Food and Drug Administration announcement late on Friday that grants an emergency use authorization to the company's blood p
The Best-Performing Small-Cap Stocks YTD: April 2020
02:00pm, Monday, 13'th Apr 2020
We screen the Russell 2000 stocks to highlight the biggest winners in 2020. Several healthcare company stocks benefiting from the coronavirus pandemic are among
RIG, OKE among premarket gainers
01:21pm, Monday, 13'th Apr 2020
SCWorx (NASDAQ:WORX) +171% on order for 2M COVID-19 blood tests.Can-Fite BioPharma (NYSEMKT:CANF) +46% on study of lead drug in COVID-19.Independence Contract Drilling (NYSE:ICD) +32%.BioCryst Pha
U.S. FDA Grants CytoSorb® Emergency Use Authorization for Use in Patients with COVID-19 Infection
11:43am, Monday, 13'th Apr 2020
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically
20 Healthcare Stocks Moving In Monday's Pre-Market Session
11:39am, Monday, 13'th Apr 2020
Gainers
• Biocept, Inc. (NASDAQ:BIOC) stock moved upwards by 55.72% to $0.56 during Monday's pre-market session.
• BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stock...
30 Stocks Moving in Monday's Pre-Market Session
10:56am, Monday, 13'th Apr 2020
Gainers
Biocept, Inc. (NASDAQ: BIOC) shares rose 68.3% to $0.5997 in pre-market trading. Biocept disclosed that it has verified a COVID-19 molecular diagnostic test.
U.S. Well...
Cypress Capital Group Invests $139,000 in Cytosorbents Corp (NASDAQ:CTSO)
09:24am, Thursday, 09'th Apr 2020
Cypress Capital Group purchased a new stake in Cytosorbents Corp (NASDAQ:CTSO) during the first quarter, HoldingsChannel.com reports. The firm purchased 18,000 shares of the medical research company�
Raymond James & Associates Sells 76,500 Shares of Cytosorbents Corp (NASDAQ:CTSO)
11:12am, Monday, 06'th Apr 2020
Raymond James & Associates cut its position in shares of Cytosorbents Corp (NASDAQ:CTSO) by 34.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities
CytoSorbents Corporation (NASDAQ: CTSO) a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically-
